The case for thyroid surgery [Differentialindikation zur Schilddrüsenoperation]

被引:0
|
作者
Köbberling J. [1 ,2 ]
Hintze G.
机构
[1] Medizinische Klinik, Ferdinand-Sauerbruch-Klinikum, Wuppertal
[2] Medizinische Klinik, Ferdinand Sauerbruch-Klinikum, Arrenberger Straße 20
来源
Der Chirurg | 1999年 / 70卷 / 9期
关键词
Autonomy; Goitre; Hyperthyroidism; Therapy goal; Thyroid cancer;
D O I
10.1007/s001040050754
中图分类号
学科分类号
摘要
Although the case for thyroid surgery is based on morphologic and physiologic criteria, it is mainly based on individual therapeutic goals. The goals are influenced by various biographic, medical and personal facts and by many environmental conditions. Thus, there is no rationale for cataloguing indications. With the euthyroid goitre the indication for surgery is usually given by the size of the thyroid gland, especially since it has become clear in various studies that with drug therapy the achievable size reduction is rather small. With Graves' disease the pros and cons of the three main methods, surgery, medical treatment or radioiodine, have to be considered in each case. Surgery is mainly indicated when the goal is a rapid and reliable normalization of the hormonal status. Thyroid autonomy is a clear-cut case for radioiodine. Only isolated autonomous nodules can equally well be treated by surgery. In addition, a case for surgery is given when besides the autonomy a large goitre is present. A special indication is iodine-induced thyrotoxicosis that cannot be normalized by medical treatment. All kinds of thyroid carcinoma, with very few exceptions, usually have to be operated on as the first choice.
引用
收藏
页码:971 / 979
页数:8
相关论文
共 50 条
  • [31] Arrhythmien bei SchilddrüsenerkrankungenArrhythmias in thyroid dysfunction
    Roman Brenner
    Stefan Bilz
    Sonia Busch
    Hans Rickli
    Peter Ammann
    Micha T. Maeder
    Herzschrittmachertherapie + Elektrophysiologie, 2024, 35 (3) : 183 - 192
  • [32] Epidemiologie des SchilddrüsenkarzinomsEpidemiology of thyroid cancer
    Chr. Reiners
    M. Geling
    M. Luster
    J. Farahati
    U. Mäder
    Der Onkologe, 2005, 11 (1): : 11 - 19
  • [33] Wiederholungseingriffe beim SchilddrüsenkarzinomReoperation for thyroid cancer
    H. Vogelsang
    T. Brückner
    K. Scheidhauer
    M. Schwaiger
    J. R. Siewert
    Der Chirurg, 2005, 76 (3): : 238 - 249
  • [34] Neues zur systemischen Therapie des medullären SchilddrüsenkarzinomsNew aspects of systemic therapy of medullary thyroid cancer
    M. Fassnacht
    R. Schmidmaier
    M. Kroiss
    M.C. Kreissl
    Der Onkologe, 2013, 19 (3): : 209 - 215
  • [35] Medulläres SchilddrüsenkarzinomVon den genetischen Grundlagen zur KlinikMedullary thyroid carcinomaFrom genetic principles to clinical aspects
    Karin Frank-Raue
    Friedhelm Raue
    Der Onkologe, 2019, 25 (7): : 573 - 579
  • [36] Hereditäre SchilddrüsenkarzinomeHereditary thyroid cancer
    H. Dralle
    A. Machens
    K. Lorenz
    Der Chirurg, 2008, 79 (11):
  • [37] Chirurgie der SchilddrüsenkarzinomeSurgery of thyroid carcinoma
    H. Dralle
    K. Lorenz
    A. Machens
    Der Chirurg, 2009, 80 (11): : 1069 - 1084
  • [38] Sterilität und SchilddrüseSterility and the thyroid
    O.E. Janßen
    Der Gynäkologe, 2009, 42 (8):
  • [39] Pathologie des SchilddrüsenkarzinomsPathology of thyroid cancer
    K. W. Schmid
    S.-Y. Sheu
    M. Tötsch
    R. Görges
    A. Bockisch
    K. Mann
    Der Onkologe, 2005, 11 (1): : 29 - 39
  • [40] Kalzitoninbestimmung zur Frühdiagnose des medullären SchilddrüsenkarzinomsCalcitonin determination for early diagnosis of medullary thyroid cancer
    W. Karges
    Der Chirurg, 2010, 81 (7): : 620 - 626